Showing results 1 to 2 of 2
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma Kim, Tae Woo; Kim, Yujin; Keum, Hyeongseop; Jung, Wonsik; Kang, Minho; Jon, Sangyong, MOLECULAR THERAPY-ONCOLYTICS, v.26, pp.1 - 14, 2022-09 |
Engineering and cytosolic delivery of a native regulatory protein and its variants for modulation of ERK2 signaling pathway Ryou, Jeong-Hyun; Sohn, Yoo-Kyoung; Kim, Dong-Gun; Kyeong, Hyun-Ho; Kim, Hak-Sung, BIOTECHNOLOGY AND BIOENGINEERING, v.115, no.4, pp.839 - 849, 2018-04 |
Discover